Future regulatory changes such as the EU’s incoming Integrated Reporting Framework (IReF) will be seamlessly integrated into the Nasdaq AxiomSL platform ensuring timely and cost-effective ...
Investors are digesting better-than-expected inflation data and bracing for the next move in Trump's escalating trade war.
TARRYTOWN, N.Y., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...
Nvidia (NVDA) has taken legal action against EU antitrust regulators, filing a lawsuit with the Luxembourg-based General Court over their decision to accept an Italian referral to scrutinize its ...
Investors are digesting better-than-expected inflation data and bracing for the next move in Trump's escalating trade war.
Adjusted operating loss is expected to be less than $495 million. EU Approval to Merck’s Welireg for Two Indications The European Commission approved Merck’s Welireg as a monotherapy for ...
Koninklijke Philips N.V. PHG has expanded its cloud-based radiology informatics solutions in Europe, enhancing access to AI-driven workflows and innovation. This move follows the successful ...
The centralized marketing authorization of KOSTAIVE is valid in all EU member states and in the ... and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...
The Dow is currently -414 points, the S&P 500 -71, the Nasdaq -326 and the small-cap Russell ... had thought a burgeoning trade war between the EU and the U.S. may have signaled a more cautious ...
Investors are digesting better-than-expected inflation data and bracing for the next move in Trump's escalating trade war.
Stock indexes retreated on Tuesday, with the S&P 500 and Nasdaq 100 falling to 4-month lows ... The European Union (EU) proposed extending 150 billion euros in loans to boost defense spending ...
Feb. 20, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO ... for use in adult patients with ATTR-CM in the EU. Preliminary results from the ongoing ATTRibute-CM open-label ...